Mimotopes-002
Non‑Small‑Cell Lung Cancer (PD-L1)
Phase 1Active
Key Facts
About Mimotopes
A peptide‑mimotope platform company creates targeted vaccines and diagnostics for oncology and immunology.
View full company profileNon‑Small‑Cell Lung Cancer (PD-L1)
A peptide‑mimotope platform company creates targeted vaccines and diagnostics for oncology and immunology.
View full company profile